2021
DOI: 10.1159/000515048
|View full text |Cite
|
Sign up to set email alerts
|

When Paranoia Comes with the Treatment: Psychosis Associated with Tacrolimus Use

Abstract: Tacrolimus is an immunosuppressive drug frequently used in solid organ transplant recipients. This drug has well-documented neuropsychiatric side effects in the literature, although emergence of psychotic symptoms is rare, being only described in a very few case reports. We present a case of a renal transplant recipient with no prior psychiatric history, who developed a severe psychosis secondary to supratherapeutic tacrolimus’ blood concentrations. This case highlights the importance of clinical awareness to … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 14 publications
(30 reference statements)
0
2
0
Order By: Relevance
“…after transplantation whereas having been on longterm CNI within the therapeutic range [43,44]. These findings highlight the need for considering immunosuppressive agents as a potential etiology when transplant patients present to the ICU with severe CNS abnormalities.…”
Section: Central Nervous System Complicationsmentioning
confidence: 91%
See 1 more Smart Citation
“…after transplantation whereas having been on longterm CNI within the therapeutic range [43,44]. These findings highlight the need for considering immunosuppressive agents as a potential etiology when transplant patients present to the ICU with severe CNS abnormalities.…”
Section: Central Nervous System Complicationsmentioning
confidence: 91%
“…Cases of severe neurological complications presenting several years after transplantation have been described in patients receiving CNI based immunosuppression. These include cases of catatonia and severe psychosis presenting greater than 16 years after transplantation whereas having been on long-term CNI within the therapeutic range [43,44]. These findings highlight the need for considering immunosuppressive agents as a potential etiology when transplant patients present to the ICU with severe CNS abnormalities.…”
Section: Complications Of Immunosuppressive Therapy: What To Watch Formentioning
confidence: 99%